CANCER RESEARCH AND TREATMENT FUND INC (EIN 136272085) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1968

Legal Domicile

Principal Officer

RICHARD TSILVER MD

Phone

2122886604

Tax Period

2024-01-01 to 2024-12-31

CANCER RESEARCH AND TREATMENT FUND INC, founded in 1968, is a community nonprofit that reported $1.1M in total revenue in fiscal year 2024. Revenue grew 12% year-over-year, indicating healthy expansion. Expenses of $1.0M left a modest 12% surplus.

Mission

TO PROVIDE RESOURCES FOR STATE OF THE ART RESEARCH THAT LEADS TO EFFECTIVE TREATMENT OF CANCERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $776,111

Program Service Revenue $0

Investment Income $510,544

Other Revenue $-139,785

TOTAL REVENUE $1,146,870

Expense Breakdown

Grants Paid $542,650

Salaries & Benefits $293,357

Fundraising Expenses $149,870

Program Expenses $788,394

Other Expenses $168,865

TOTAL EXPENSES $1,004,872

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,146,870	$1,026,414	+0.1%
Expenses	$1,004,872	$1,011,255	0.0%
Net Income	$141,998	$15,159	+8.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$120,000

Total Directors

$120,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RICHARD TSILVER MD	Director	40.00	Officer Director	$120,000	$0	$120,000
DAVID BOULE	Director	3.00	Officer Director	$0	$0	$0
RICHARD ROSE	Director	1.00	Director	$0	$0	$0
TODD SHAW	Director	1.00	Director	$0	$0	$0
ADAM SILVER	Director	1.00	Director	$0	$0	$0
CALEB SEXTON	Director	1.00	Director	$0	$0	$0
JEFFREY PUGLISIMD	Director	0.00	Director	$0	$0	$0
AMANDA JOHNS PEREZ	Director	1.00	Director	$0	$0	$0
RAJESH SHAH	Director	1.00	Director	$0	$0	$0
TERRY HERMANSON	Director	1.00	Director	$0	$0	$0
MICHAEL C KEMPNER	Director	1.00	Director	$0	$0	$0
MARIA BRISBANE	Director	1.00	Director	$0	$0	$0
KASIA McCORMICK	Director	1.00	Director	$0	$0	$0
NELSON BOXER	Director	1.00	Officer Director	$0	$0	$0
TIM SILVER	Director	1.00	Director	$0	$0	$0
AJ SHIEKMAN	Director	1.00	Director	$0	$0	$0
THOMAS SILVER	Director	3.00	Officer Director	$0	$0	$0
ANNE TEMPLETON	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,146,870	$1,004,872	$15,194,701	$141,998
2023	$1,026,414	$1,011,255	$13,748,310	$15,159
2022	$573,018	$957,125	$12,581,316	$-384,107
2021	$1,096,322	$810,847	$14,862,676	$285,475
2020	$1,420,266	$808,875	$13,981,569	$611,391
2019	$1,228,731	$1,170,832	$12,971,652	$57,899
2018	$1,593,864	$1,137,755	$11,251,052	$456,109

CANCER RESEARCH AND TREATMENT FUND INC